- Our process Every year we carefully invest a proportion of our income into our research. Underpinning the research is our commitment to the highest standards; as part…
- Cutting edge treatment In 2022, at 13 years old, Alyssa became the first patient in the world to be treated with a new therapy using cutting edge genetic technology to…
- 2025's Research: Wrapped! Research is a fundamental part of what we do at Anthony Nolan. Without research, we wouldn’t be able to advance the science behind stem cell…
- How Anthony Nolan’s research is improving transplant equity so that one day, every patient can survive and thrive. A stem cell transplant can be a lifesaving treatment for…
- The potential of transplant data Stem cell transplants can save lives, but we have so much more to understand about how they work and how we can improve them so that…
- At Anthony Nolan, over a third of our 300 staff are scientists. Our research team is always taking on groundbreaking new initiatives to improve transplantation and quality of life…
- On 6 January George Freeman, Life Sciences Minister visited our Research Institute to launch our new Third Generation Sequencing technology (TGS), which will improve stem cell…
- By David Marks, Medical Director of IMPACT. Stem cell transplants give a second chance of life to 4,400 people a year in the UK (BSBMTCT 2016 report), but sadly, fewer than…
- After the news that the Scottish Medicine Consortium has recommended letermovir (Prevymis) for routine use on the NHS in Scotland, Bradley from our Policy and Public Affairs team…
- For over 45 years Anthony Nolan has recruited potential stem cell donors to their register – people who are willing to donate their cells to someone in need of a lifesaving stem…
This page has been auto translated by Google Translate. Confirm any health information with your own medical team before acting upon it. All printed materials and PDFs are available in English only.